About the Authors
- Aditi Gupta
-
Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing
* E-mail: agupta@kumc.edu
Affiliations The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, United States of America, Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, United States of America, Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, KS, United States of America
- Kevin Kennedy
-
Roles Formal analysis
Affiliation Kansas City Veterans Affairs, University of Kansas Medical Center, Kansas City, KS, United States of America
- Jaime Perales-Puchalt
-
Roles Methodology, Writing – review & editing
Affiliations Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, KS, United States of America, Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America
- David Drew
-
Roles Writing – review & editing
Affiliation Division of Nephrology and Hypertension, Tufts Medical Center, Boston MA, United States of America
- Srinivasan Beddhu
-
Roles Methodology, Writing – review & editing
Affiliation University of Utah, Salt Lake City, UT, United States of America
- Mark Sarnak
-
Roles Methodology, Writing – review & editing
Affiliation Division of Nephrology and Hypertension, Tufts Medical Center, Boston MA, United States of America
- Jeffrey Burns
-
Roles Methodology, Writing – review & editing
Affiliations Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, KS, United States of America, Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America
- the Alzheimer’s Disease Neuroimaging Initiative
-
¶A complete membership of the author group can be found in the Acknowledgments.
Competing Interests
The authors declare no conflict of interest that alters their adherence to PLOS ONE policies on sharing data and materials. AG has a consultancy agreement with Novartis Pharmaceuticals and has grant funding from Novartis and Veloxis Pharmaceuticals; none of which are relevant to the current manuscript.